Depomed (DEPO) Income Statement

Click line-items for a historical chart and %

Product sales
Royalties	221K
License and collaborative revenue
Total revenues	110.52M
Cost of sales	20.24M
Research and development expense	10.41M
Promotion fee expense
Other selling, general and administrative expense
Total selling, general and administrative expense	51.57M
Gain on settlement agreement
Total costs and expenses	109.27M
Income (loss) from operations	1.26M
Interest and other income	113K
Interest expense	-20.31M
Total other income (expense)	-20.19M
Net income (loss) before income taxes
Benefit from (Provision for) income taxes	6.04M
Net income (loss)	-12.89M
Basic net income (loss) per common share
Diluted net income (loss) per common share
Shares used in computing basic net income (loss) per common share
Shares used in computing diluted net income (loss) per common share

Entities mentioned with DEPO

View All Entities